Why Is Open-Access Hyphenation Important for Chromatographers? An HPLC Interview with John Langley
At HPLC 2023, LCGC spoke with John Langley of the University of Southampton in the UK. These clips comprise one of several HPLC interviews that were conducted at the conference.
Langley spoke with us at HPLC 2023 in Dusseldorf, Germany, where he presented and moderated on panels related to developments in supercritical fluid chromatography (SFC).
Langley is a Professor at the University of Southampton in Southampton, UK.
In these interview clips, Langley answers the following:
- What is open access hyphenation? (00:16–00:59)
- Why is open access hyphenation important in your laboratory? (01:00–01:54)
- What are the benefits of open access RP-UHPLC-MS and open access UHPSFC-MS? (01:55–02:52)
- What are the benefits of open access 2D-LC-IMS-MS? (02:53–03:51)
- Are you planning to evolve open access hyphenation further? (03:52–04:42)
- Do you have advice for analysts who want to implement open access hyphenation? (04:43–05:31)
This interview was one of several conducted at HPLC 2023. You can see our latest conference coverage, including our additional video interviews conducted at HPLC, at the following link: https://www.chromatographyonline.com/conferences/hplc
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
